Louis P T, Goddard-Finegold J, Fishman M A, Griggs J R, Stein F, Laurent J P
Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Crit Care Med. 1993 Aug;21(8):1200-6. doi: 10.1097/00003246-199308000-00021.
The purpose of this study was to determine the effect of hyperventilation alone and hyperventilation plus barbiturate therapy on intracranial pressure, global and regional cerebral blood flow rates, cerebrovascular resistance, and cerebral perfusion pressure in adult dogs with and without intracranial hypertension induced by epidural balloon.
Prospective, randomized, controlled study.
An animal laboratory of a university hospital. Four sequential global and regional cerebral blood flow determinations were made in each animal during monitoring of heart rate and systemic arterial pressure, during respiratory control and arterial blood gas monitoring, intracranial pressure monitoring, and with or without inflation of an epidural balloon catheter.
Acute mongrel dogs obtained from the Baylor Center for Comparative Medicine. Five groups of animals were studied. In group 1, the response to hyperventilation was assessed in dogs without increased intracranial pressure. In group 2, the response to hyperventilation was assessed in animals with acute intracranial hypertension. In group 3, the response to hyperventilation plus barbiturate therapy was assessed in dogs without increased intracranial pressure. In group 4, the response to hyperventilation plus barbiturate therapy was assessed in dogs with acute increased intracranial pressure. In group 5, a group of dogs with increased intracranial pressure was treated with neither hyperventilation nor barbiturates.
Hyperventilation, hyperventilation plus barbiturate therapy, or no interventions were studied in these experimental paradigms.
The main outcome measures were changes in intracranial pressure and/or changes in regional or total cerebral blood flow. A significant decrease in intracranial pressure and cerebral blood flow rate was produced by hyperventilation alone in groups with intracranial hypertension. Combined hyperventilation and barbiturate therapy resulted in a significant further decrease in cerebral blood flow rate in animals with normal and increased intracranial pressure, but no greater decrease in intracranial pressure was seen compared with treatment with hyperventilation alone. Cerebral perfusion pressures remained normal despite significant decreases in cerebral blood flow rates.
These studies suggest that barbiturate administration in this model of intracranial hypertension was no more effective in reducing increased intracranial pressure than hyperventilation alone.
本研究旨在确定单纯过度通气以及过度通气联合巴比妥类药物治疗对成年犬颅内压、全脑和局部脑血流速率、脑血管阻力及脑灌注压的影响,这些成年犬有无因硬膜外球囊诱导的颅内高压。
前瞻性、随机、对照研究。
一所大学医院的动物实验室。在每只动物监测心率和体动脉压期间、呼吸控制和动脉血气监测期间、颅内压监测期间以及硬膜外球囊导管充气或未充气的情况下,依次进行四次全脑和局部脑血流测定。
从贝勒比较医学中心获得的急性杂种犬。研究了五组动物。第1组,评估无颅内压升高的犬对过度通气的反应。第2组,评估患有急性颅内高压的动物对过度通气的反应。第3组,评估无颅内压升高的犬对过度通气联合巴比妥类药物治疗的反应。第4组,评估患有急性颅内压升高的犬对过度通气联合巴比妥类药物治疗的反应。第5组,一组颅内压升高的犬既未接受过度通气治疗也未接受巴比妥类药物治疗。
在这些实验范式中研究了过度通气、过度通气联合巴比妥类药物治疗或不进行干预。
主要观察指标为颅内压变化和/或局部或全脑血流变化。在颅内高压组中,单纯过度通气可使颅内压和脑血流速率显著降低。过度通气联合巴比妥类药物治疗使颅内压正常和升高的动物脑血流速率进一步显著降低,但与单纯过度通气治疗相比,颅内压降低幅度未见更大。尽管脑血流速率显著降低,但脑灌注压仍保持正常。
这些研究表明,在该颅内高压模型中,巴比妥类药物给药在降低升高的颅内压方面并不比单纯过度通气更有效。